by The facial injectable market was valued at USD 12.25 billion in 2021 and is projected to reach $28.13 billion by 2030, growing at a CAGR of 9.7% from 2022 to 2030.
The dermal fillers often known as facial injectables, are treatments that help with facial rejuvenation. These injectable face solutions are primarily intended to alleviate early indicators of ageing such as wrinkles and to enhance aesthetic appearance.
Download Exclusive Sample of Report@ https://www.precedenceresearch.com/sample/1594
There has been a significant growth in disposable incomes worldwide, as well as rise in aesthetic attractiveness consciousness. As a result, as more people choose to improve their physical appearances, attitudes around cosmetic operations have shifted. A growing number of people are choosing for minimally invasive procedures like facial injectables since they are considered safer and require little to no delay. The neurotoxins like botulinum toxin as well as dermal fillers like hyaluronic acid and calcium hydroxylaptite are among the facial injectables available in the market.
The need for cosmetic procedures is being driven by an increase in the number of plastic surgeons and their networks, which is in turn increasing the demand for facial injectables. There was also Food & Drug Administration (FDA) authorization for other practitioners including as surgeons to utilize facial injectable in their clinics. The healthcare practitioners can now perform facial injectable procedures because they encounter many patients requiring facial transformation after dental treatments. The facial injectable market is likely to develop as a result of this factor.
Report Scope of the Facial Injectable Market
| Report Coverage | Details |
| Market Size by 2030 | USD 28.13 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 9.7% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Application, End User, Generation, Geography |
Report Highlights
- Based on the product, the botulinum toxin Type A segment dominated the global facial injectable market in 2020 with highest market share. The botulinum toxin Type A in its cosmetic version, known to patients as Botox, is a popular injection that temporarily reduces or removes facial small lines and wrinkles. The forehead creases and frown lines are the most typically treated locations.
- North America is the largest segment for facial injectable market in terms of region. North America controlled the facial injectable market and has a high level of knowledge regarding the state of healthcare and its costs.
- Asia-Pacific region is the fastest growing region in the facial injectable market. The higher awareness about aesthetic surgical procedures, the presence of key market players, and an increasing geriatric population, technological advancements, and demand for minimally invasive aesthetic procedures are some of the factors driving the growth of the facial injectable market in the Asia-Pacific region.
Purchase this report (Price 4500 USD for a single-user license) @ https://www.precedenceresearch.com/checkout/1594
Market Dynamics
Drivers
The surge in demand for aesthetic procedures
The increased awareness has resulted in an increase in demand for aesthetic procedures. Furthermore, as developing countries around the world improve economically, disposable income has risen dramatically. As a result, an increasing number of people are opting for various filler injections to improve their aesthetic appearance. There has also been a considerable shift in attitudes about these cosmetic treatments, reducing the stigma associated with them. As a result, the surge in demand for aesthetic procedures will drive the growth of the global facial injectable market during the forecast period.
Restraints
High cost of facial injectables
The average cost of hyaluronic acid fillers is $682 per syringe, according to American Society of Plastic Surgeons (ASPS) price data from 2018. To attain the intended results, most people will need more than one syringe. Botox, on the other hand, is sold in units and costs between $10 and $15 each unit. For example, to treat the forehead and eye area, an average dosage of 30-40 units might be employed, resulting in a total cost of $300 to $600. Thus, the high cost of facial injectables is hindering the market growth.
Opportunities
Surge in adoption of facial injectable
An increasing proportion of the male population is predicted to adopt facial injectable in the forecast period, which is one of the most unique and widespread trends in the worldwide market. During the forecast period, this particular trend is expected to contribute positively to the facial injectable market growth. Additionally, because males do not want a more apparent improvement of their facial characteristics, less invasive procedures such as botulinum toxin are a popular alternative. More males are predicted to use facial injectables rather than invasive cosmetic procedures as a result of this. The facial injectable growth is projected to be aided by such developments.
Challenges
Side effects of the treatments
The market for facial injectables is projected to be hampered by the negative effects associated with dermal injectables over the forecast period. The injection technique used by the healthcare provider, for example, can influence whether or not the patient has bruise and stiffness. The rapid filler injection and the use of large number of fillers have all been proven to enhance the risk of bruising. Furthermore, if the filler is injected too superficially, it can create a bluish discoloration of the skin covering the filler in some cases. As a result, the side effects of the treatments are a major challenge for the growth of the global facial injectable market during the forecast period.
Regional Insights
North America dominated the market and accounted for the largest revenue share of more than 41% in 2020. This growth is owing to the large geriatric population in the U.S. and Canada is anticipated to propel the demand for facial injectables over the forecast period.
In the Asia Pacific, the market is projected to witness the highest CAGR of 10% during the forecast period. The region is backed by countries such as India, Australia, and South Korea. Growing focus on the physical appearance in these developing countries is expected to play a key role in the demand for facial injectable treatment. India is projected to be the fastest-growing during the forecast period.
Some of the prominent players in the global facial injectable market include:
- Johnson & Johnson
- Syneron Candela
- Lumenis
- Hologic
- Solta Medical
- Alma Laser
- Galderma
- Dickinson and Company
- Antares Pharma
- Novartis AG
Segments Covered in the Report
By Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylaptite (CaHA)
- Polymer Fillers
- Others
By Application
- Aesthetics
- Therapeutics
End User
- Hospitals
- Specialty Clinics
- Spa & Beauty Clinics
By Generation
- Gen X
- Boomer
- Millennials
Regional Segmentation
• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia],
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland],
• North America [United States, Canada, Mexico],
• South America [Brazil, Argentina, Columbia, Chile, Peru].
• Middle East & Africa [GCC, North Africa, South Africa],
Why should you invest in this report?
If you are aiming to enter the global xxx market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for xxx market are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Facial Injectable Market
5.1. COVID-19 Landscape: Facial Injectable Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Facial Injectable Market, By Product
8.1. Facial Injectable Market, by Product Type, 2022-2030
8.1.1. Collagen
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Hyaluronic Acid (HA)
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Botulinum Toxin Type A
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Calcium Hydroxylaptite (CaHA)
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Polymer Fillers
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Facial Injectable Market, By Application
9.1. Facial Injectable Market, by Application, 2022-2030
9.1.1. Aesthetics
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Therapeutics
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Facial Injectable Market, By End User
10.1. Facial Injectable Market, by End User Type, 2022-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Specialty Clinics
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Spa & Beauty Clinics
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Facial Injectable Market, By Generation
11.1. Facial Injectable Market, by Generation Type, 2022-2030
11.1.1. Gen X
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Boomer
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Millennials
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Facial Injectable Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.1.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.2.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.3.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.4.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.5.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Generation Type (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.3. Market Revenue and Forecast, by End User Type (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Generation Type (2017-2030)
Chapter 13. Company Profiles
13.1. Johnson & Johnson
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Syneron Candela
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Lumenis
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Hologic
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Solta Medical
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Alma Laser
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Galderma
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Dickinson and Company
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Antares Pharma
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Novartis AG
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Buy Exclusive Report@ https://www.precedenceresearch.com/checkout/1594
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
